MARKET

SHIEF

SHIEF

Shield Therapeut
OTCMQB
0.080
NaN%
Closed 09:30 06/30 EDT
OPEN
--
PREV CLOSE
0.080
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.168
52 WEEK LOW
0.039
MARKET CAP
85.56M
P/E (TTM)
-4.7337
1D
5D
1M
3M
1Y
5Y
1D
Shield Therapeutics issues shares under performance plan while keeping other incentive schemes unchanged
TipRanks · 1d ago
Shield Therapeutics issues 2,023,801 shares under retention and performance share plan block listing return
PUBT · 1d ago
Shield Therapeutics Secures Strong Shareholder Backing at 2026 AGM
TipRanks · 06/18 15:27
Shield Therapeutics updates share capital as iron deficiency franchise expands globally
TipRanks · 05/29 08:17
Shield Therapeutics awards CEO new share options to support growth of iron drug franchise
TipRanks · 05/05 06:24
Shield Therapeutics posts profitable Q1 as ACCRUFeR sales surge and CFO departs
TipRanks · 05/01 06:18
Shield Therapeutics Updates Total Voting Rights and Highlights Global Iron Therapy Franchise
TipRanks · 04/30 06:49
Shield Therapeutics Starts Japanese Phase II Trial of ACCRUFeR in Pulmonary Arterial Hypertension
TipRanks · 04/27 06:13
More
About SHIEF
Shield Therapeutics plc is a United Kingdom-based commercial-stage pharmaceutical company. The Company delivers differentiated specialty pharmaceuticals that address a significant unmet need for patients suffering from iron deficiency, with or without anemia. The Company’s lead product, Accrufer/Feraccru, is broadly indicated for use in adults across multiple therapeutic categories. Ferric maltol is approved in the United States, European Union, the United Kingdom, Canada, Australia and Switzerland for the treatment of iron deficiency with or without anemia in adults. It also has an exclusive licence agreement with Beijing Aosaikang Pharmaceutical Co., Ltd., for the development and commercialization of ACCRUFeR/FeRACCRU in China, Hong Kong, Macau and Taiwan, with Korea Pharma Co., Ltd. for the Republic of Korea. The Company's subsidiaries include Phosphate Therapeutics Limited, Shield TX (Switzerland) AG, Shield Therapeutics Inc, and Shield TX (UK) Limited.

Webull offers Shield Therapeutics PLC stock information, including OTCMQB: SHIEF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SHIEF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SHIEF stock methods without spending real money on the virtual paper trading platform.